Trend Arrows and
Scanning through the Day
(more than 0.1 mmol/L per minute)
(between 0.06-0.1 mmol/L per minute)
(less than 0.06 mmol/L per minute)
(between 0.06-0.1 mmol/L per minute)
(more than 0.1 mmol/L per minute)
If a calculation on falling glucose takes you into the hypo zone (below 3.9 mmol/L) then you still have the opportunity to take action and bring your glucose back to target1.
There are many factors influencing glucose levels. Low glucose can be caused by a range of things, Many things can affect your glucose levels, such as
So although this is useful to know, it’s important to understand that this is only for guidance and a glucose reading can be taken at any time by scanning the FreeStyle Libre sensor if you are unsure.
Studies have demonstrated greater glucose control benefits are associated with increased scanning frequency using the FreeStyle Libre system.1,2
Scanning upon waking up helps uncover glucose levels while you are asleep.
Scanning the sensor first thing in the morning will provide the last 8-hour view of glucose levels throughout the night.
Scanning prior to meals will allow you to understand where glucose levels are before eating.
Current glucose readings and trend arrow as part of your insulin dose calculation.
Glucose levels often change dramatically following a meal. Scanning after a meal helps you evaluate food choices and treatment decisions.
Pre-exercise scanning will determine whether activity will be safe and/or if any corrective actions are needed. In addition to scanning before exercise, consider scanning during and after activities to monitor potential delayed hypoglycemia.
Scanning before bedtime enables you to evaluate their current glucose level and determine if corrective action is needed before falling asleep.
1. Bolinder J, Antuna R, Geelhoed-Duijvestijn P, Kr¨oger J, Weitgasser R. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet. 2016;388(10057):2254–2263.
2. Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline JP, Rayman G. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial. Diabetes Ther. 2017;8(1):55–73.
– Images are for illustrative purposes only. Not real patient or Health Care Professional.
– Simulated data for illustrative purposes only. Not real patient or data.
Clicking the "Yes" link below will take you to a website other than Abbott Laboratories. Links that direct you to other sites are not under the control of Abbott Laboratories. Abbott Laboratories is therefore not responsible for the content of such websites or for any other links that may appear on this website. Abbott Laboratories provides these links only as a courtesy, and the inclusion of a link does not imply approval of Abbott Laboratories for this page.
Leaving Page?
This is a product-specific website exclusively for people residing in Bahrain. If you live in another country, please contact your local Abbott representative to obtain the correct product information for your country of residence (click “Go to worldwide”). To visit the local site in English, click “Stay here” or access the local page in Arabic by clicking on freestyle.abbott/bh-ar
هذا موقع خاص بالمنتج حصريًا للأشخاص المقيمين في البحرين. إذا كنت تعيش في بلد آخر، فيرجى التواصل مع ممثل شركة أبوت المحلي لديك للحصول على معلومات المنتج الصحيحة لبلد إقامتك (انقر على "الانتقال إلى الموقع العالمي"). لزيارة الموقع المحلي باللغة العربية، انقر على "البقاء هنا" أو قم بزيارة الصفحة المحلية باللغة الإنجليزية بالنقر على freestyle.abbott/bh-en
Stay Connected